World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
37017
World Ranking
11170
National Ranking
343

Overview

Khê Hoang-Xuan is affiliated with Université Paris Cité in France and has a substantial body of work primarily within the field of Medicine. Their research spans multiple subfields including Neurology, Genetics, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, and Oncology.

The main focus of their research includes topics such as Glioma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Brain Metastases and Treatment, Long-Term Effects of COVID-19, CAR-T cell therapy research, and Radiomics and Machine Learning in Medical Imaging.

Recent notable publications include:

  • Mechanisms and therapeutic implications of hypermutation in gliomas, 2020, Nature
  • Management and outcome of primary CNS lymphoma in the modern era, 2020, Neurology
  • Primary central nervous system lymphoma, 2023, Nature Reviews Disease Primers
  • The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study, 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification, 2020, Neuro-Oncology

Frequent coauthors collaborating with Khê Hoang-Xuan include Caroline Houillier, Sylvain Choquet, Carole Soussain, Karima Mokhtari, and Agustí Alentorn. This reflects a consistent multidisciplinary collaborative network contributing to shared research interests.

Their publications have appeared predominantly in specialized journals focused on neurological and oncological diseases. Key publication venues include Neuro-Oncology, Revue Neurologique, Neurology, Journal of Neuro-Oncology, and Hematological Oncology.

Best Publications

  • Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

    Olivier L. Chinot;Wolfgang Wick;Warren Mason;Roger Henriksson

  • Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

    Guy A. Rouleau;Philippe Merel;Mohini Lutchman;Marc Sanson;Marc Sanson

  • Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

    MJ van den Bent;D Afra;O de Witte;M Ben Hassel

  • Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

    Martin J. van den Bent;Alba A. Brandes;Martin J.B. Taphoorn;Johan M. Kros

  • Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas

    Marc Sanson;Yannick Marie;Sophie Paris;Ahmed Idbaih

  • Primary brain tumours in adults

    Anthony Behin;Khe Hoang-Xuan;Antoine F Carpentier;Jean-Yves Delattre

  • Genome-wide association study identifies five susceptibility loci for glioma

    Sanjay Shete;Fay J. Hosking;Lindsay B. Robertson;Sara E. Dobbins

  • Clinical trial of blood-brain barrier disruption by pulsed ultrasound

    Alexandre Carpentier;Michael Canney;Alexandre Vignot;Vincent Reina

  • Mechanisms and therapeutic implications of hypermutation in gliomas.

    Mehdi Touat;Mehdi Touat;Mehdi Touat;Yvonne Y. Li;Yvonne Y. Li;Adam N. Boynton;Adam N. Boynton;Liam F. Spurr;Liam F. Spurr

  • IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

    C. Houillier;X. Wang;G. Kaloshi;K. Mokhtari

  • Guidelines on management of low-grade gliomas: report of an EFNS–EANO* Task Force

    R Soffietti;B G Baumert;L Bello;A von Deimling

  • The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20.

    T.J. Postma;N.K. Aaronson;J.J. Heimans;M.J. Muller

  • Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

    Brigitta G Baumert;Brigitta G Baumert;Monika E Hegi;Martin J van den Bent;Andreas von Deimling

  • Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

    M. Brada;K. Hoang-Xuan;R. Rampling;P. Y. Dietrich

  • A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: Analysis of 83 cases

    Sophie Camilleri-Broët;Emmanuelle Crinière;Philippe Broët;Vincent Delwail

  • Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions

    K. Hoang-Xuan;L. Capelle;M. Kujas;S. Taillibert

  • Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

    Carole Soussain;Khê Hoang-Xuan;Luc Taillandier;Emmanuelle Fourme

  • Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

    Khê Hoang-Xuan;Eric Bessell;Jacoline Bromberg;Andreas F Hottinger

  • Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

    Nicolas Sévenet;Arielle Lellouch-Tubiana;Deborah Schofield;Khe Hoang-Xuan

  • Chemotherapy Alone as Initial Treatment for Primary CNS Lymphoma in Patients Older Than 60 Years: A Multicenter Phase II Study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group

    K. Hoang-Xuan;L. Taillandier;O. Chinot;P. Soubeyran

Frequent Co-Authors

Ahmed Idbaih
Ahmed Idbaih Sorbonne University
Marc Sanson
Marc Sanson Sorbonne University
Jean-Yves Delattre
Jean-Yves Delattre Université Paris Cité
Olivier Delattre
Olivier Delattre PSL University
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Roger Stupp
Roger Stupp Northwestern University
Alba A. Brandes
Alba A. Brandes Institute of Neurological Sciences
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Jean Donadieu
Jean Donadieu University of Paris-Saclay
Dominique Figarella-Branger
Dominique Figarella-Branger Aix-Marseille University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering medicine in the USA, there are several alternative or supporting career paths available through online education. Many students choose to start with nursing, utilizing online nursing programs for flexible, affordable entry into the healthcare field. These programs provide essential clinical knowledge and can be completed while balancing work or family commitments.

Registered nurses looking to expand their skills and career prospects may pursue advanced education through rn to bsn online degrees. These programs typically help nurses qualify for leadership roles and higher salaries.

For those interested in the highest levels of nursing education and research, online phd nursing pathways allow professionals to contribute to the advancement of healthcare through teaching or policy work.

Even individuals with non-nursing backgrounds can enter the field quickly, thanks to options like the cheapest direct entry msn programs. These programs offer a fast track to a master’s degree, opening doors to a variety of nursing careers.

Best Scientists Citing Khê Hoang-Xuan

Trending Scientists